Mild or Intermediate Symptomatic Carotid Lesions: What we need to know about plaque

Ischemic stroke is the main reason behind disability in the world, and it is often followed by death. 

Carotídeas asintomáticas ¿Tenemos todas las respuestas?

The rupture of carotid atherosclerotic plaque and its embolization are the main cause of this entity. 

Different randomized studies have shown that carotid endarterectomy is beneficial in symptomatic patients with 70 to 99% carotid obstruction, but we still need to find evidence to establish the best treatment for mild and intermediate lesions. 

The PARISK study, an observational multicenter prospective trial, included 238 patients with a history of transient ischemic attack (TIA)  or monocular stroke, TIA or minor carotid stroke with mild to moderate ipsilateral carotid lesion. 

Patients were looked at using magnetic resonance imaging (MRI) and computed tomography angiography (AngioTAC) to look at four carotid plaque properties: presence of intraplaque hemorrhage (MRI), (ulceration (AngioTAC), proportion of calcifications (AngioTAC), and total plaque volume (MRI). 

Read also: Symptomatic Carotid Arteries: Early or Late Emergency Revascularization?

Mean age was 69, 71% were men, 86% were hypertensive, 26% diabetic, 49% had a history of myocardial ischemia.

45% presented TIA, 44% stroke and 111% stroke or monocular TIA.

Carotid obstruction (ECST risk score) was 0 to 30% in 73% of patients, 30 to 49% in 23%, and 50 to 69% in the remaining 4%.  

There was 39% intraplaque hemorrhage, 27% ulceration, 7.3% calcification and 1281.5 µL total plaque volume. 

Read also: Asymptomatic Carotid Lesions and Cognitive Impairment: Does Intervention Play a Role?

At 5 year-followup TIA or stroke was associated to presence and total volume of intraplaque hemorrhage (HR: 2.12 [95% CI: 1.02-4.44] for IPH; HR: 1.07 [95% CI: 1.00-1.15] for total plaque volume per 100 µL increase).

Ulcerations and calcifications were not associated to events. 

Conclusion

Intraplaque hemorrhage and total plaque volume are independent risk factor of TIA or recurrent ipsilateral stroke in patients with mild to moderate carotid stenosis. Plaque characteristics will improve decision making. Further study is required to validate plaque characteristics and its implementation in clinical scores. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Carotid Plaque Characteristics Predict Recurrent Ischemic Stroke and TIA. The PARISK (Plaque At RISK) Study.

Reference: Dianne H.K. van Dam-Nolen, et a. J Am Coll Cardiol Img 2022;15:1715–1726.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...

IVUS-Guided vs. Angiography-Guided Drug-Coated Balloon Angioplasty in the Treatment of Femoropopliteal Lesions

Angiography has traditionally been the primary imaging technique for endovascular therapy guidance in patients with peripheral artery disease. However, as it only provides two-dimensional...

New Carotid PCI All-in-One System

Carotid stenting is equivalent to carotid endarterectomy in terms of major adverse events (death, AMI, and stroke). However, it entails higher risk of minor...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...